title: Nivolumab for Refractory Anaplastic Large Cell Lymphoma: A Case Report.
authors.affiliation: From Stauferklinikum Schwaeb. Gmuend, Mutlangen, Germany; Eberhard Karls University Tuebingen, Tuebingen, Germany; and Justus Liebig University Giessen, Giessen, Germany.
authors.forename: Holger
authors.initials: H
authors.lastname: Hebart
authors.affiliation: From Stauferklinikum Schwaeb. Gmuend, Mutlangen, Germany; Eberhard Karls University Tuebingen, Tuebingen, Germany; and Justus Liebig University Giessen, Giessen, Germany.
authors.forename: Peter
authors.initials: P
authors.lastname: Lang
authors.affiliation: From Stauferklinikum Schwaeb. Gmuend, Mutlangen, Germany; Eberhard Karls University Tuebingen, Tuebingen, Germany; and Justus Liebig University Giessen, Giessen, Germany.
authors.forename: Wilhelm
authors.initials: W
authors.lastname: Woessmann
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D017728:Lymphoma, Large-Cell, Anaplastic / Q000188:drug therapy*; D008297:Male; D000077594:Nivolumab; D012074:Remission Induction; D055815:Young Adult
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D000077594:Nivolumab